Features of the new Macroduct Advanced include a touch screen user interface with built-in step-by-step graphical instructions that further standardize pilocarpine iontophoresis and sweat collection for optimum results.
In addition, the revised shape of electrodes and Macroduct collector offer greater convenience when working with neonates and toddlers with small limbs.
This system truly is meant to enhance laboratory workflow in meeting protocols and traceability requirements with flexible options for data management.
ELITechGroup Biomedical Systems is in the laboratory diagnosis of cystic fibrosis with the proven products for sweat stimulation, collection, and analysis.
The company is also a key player in supporting global laboratories with the world's most advanced cytocentrifuge rotor, slide stainers, and osmometers.
Itepekimab meets primary endpoint in one of two Phase 3 COPD trials
Inogen secures FDA clearance for SIMEOX 200 Airway Clearance Device
Infex Therapeutics begins Phase IIa trial for RESP-X in NCFB patients
SalioGen Therapeutics names new chief medical officer
Destiny Pharma launches research on XF-73 for cystic fibrosis MRSA infections
Polarean Imaging enters into trade-in agreement with University of Kansas Medical Center
Sionna Therapeutics doses first healthy subject in SION-109 phase one clinical trial
Arcturus Therapeutics granted FDA Orphan Drug Designation for ARCT-032 to treat cystic fibrosis